Lactic acid bacteria — promising vaccine vectors: possibilities, limitations, doubts

Journal of Applied Microbiology

Volumn 123, Issue 2, 2017, Pages 325-339

  Szatraj, K ^a   Szczepankowska, A K ^a   Chmielewska Jeznach, M ^a  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

gut microflora; heterologous gene expression; lactic acid bacteria; oral administration; vaccine vectors

Indexed keywords

ANTIGENS; BACTERIA; GENE EXPRESSION; LABORATORIES; LACTIC ACID; PROTEINS; STRAIN;

BACTERIUM STRAIN; DELIVERY SYSTEMS; GRAM POSITIVE; GUT MICROFLORA; HETEROLOGOUS GENE EXPRESSIONS; LACTIC ACID BACTERIA; ORAL ADMINISTRATION; PRODUCTION SYSTEM; SAFE PRODUCTION; VACCINE VECTORS;

VACCINES;

BACTERIAL VACCINE; VACCINE;

ANTIGEN; BACTERIUM; DIGESTIVE SYSTEM; DISEASE VECTOR; DRUG DEVELOPMENT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; INOCULATION; MICROBIAL COMMUNITY; MUCUS; PATHOGEN; PROTEIN; VACCINE;

BACTERIAL STRAIN; DNA MODIFICATION; HUMAN; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOCOCCUS LACTIS; LYMPHOID TISSUE; NONHUMAN; REVIEW; STREPTOCOCCUS GORDONII; VACCINATION; ANIMAL; GENE EXPRESSION; GENE VECTOR; GENETICS; IMMUNIZATION; IMMUNOLOGY;

POSIBACTERIA;

ANIMALS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; IMMUNIZATION; LACTOBACILLUS; VACCINES;

EID: 85017368612     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13446     Document Type: Review

References (91)

1. Alvarez, S., Gobbato, N., Bru, E., de Ruiz Holgado, A.P. and Perdigón, G. (1998) Specific immunity induction at the mucosal level by viable Lactobacillus casei: a perspective for oral vaccine development. Food Agric Immunol 10, 79–87.
2. Balasubramanya, N.N., Lokesh, B.R., Ramesh, H.P. and Krishnakantha, T.P. (1995) Effect of lactic microbes on superoxide anion generating ability of peritoneal macrophages and tissue histopathology of murines. Indian J Dairy Biosci 6, 28–33.
3. Bermúdez-Humarán, L.G., Langella, P., Miyoshi, A., Gruss, A., Tamez Guerra, R., Montes de Oca-Luna, R. and Le Loir, Y. (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68, 917–922.
4. Bhakdi, S. and Tranumjensen, J. (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55, 733–751.
5. Boguslawska, J., Zycka-Krzesinska, J., Wilcks, A. and Bardowski, J. (2009) Intra- and interspecies conjugal transfer of Tn916-like elements from Lactococcus lactis in vitro and in vivo. Appl Environ Microbiol 75, 6352–6360.
6. Campos, I.B., Darriuex, M., Ferreira, D.M., Miyaji, E.N., Silva, D.A., Areas, A.P., Aires, K.A., Leite, L.C. et al. (2008) Nasal immunization if mice with Lactobacillus casei expressing the pneumococcal surface protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge on the mouse respiratory tract. Microbes Infect 10, 481–488.
7. Capron, A., Riveau, G., Grzych, J.M., Boulanger, D., Capron, M. and Pierce, R. (1995) Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Mem Inst Oswaldo Cruz 90, 235–240.
8. Chamberlain, L.M., Wells, J.M., Robinson, K., Schofield, K.M. and Le Page., R.W.F. (1997) Mucosal immunisation with recombinant Lactococcus lactis. In Gram-Positive Bacteria as Vaccine Vehicles for Mucosal Immunization ed. Pozzi, G. and Wells, J.M. pp. 83–106. Austin, TX: Landes Bioscience.
9. De Moreno de LeBlanc, A., Maldonado Galdeano, C., Chaves, S. and Perdigon, G. (2005) Oral administration of Lactobacillus casei CRL 431 increases immunity in bronchus and mammary glands. Eur J Inflamm 3, 23–28.
10. Dubois, B., Chapat, L., Goubier, A., Papiernik, M., Nicolas, J.F. and Kaiserlian, D. (2003) Innate CD4CD25 regulatory T cells are required for oral tolerance and inhibition of CD8 T cells mediating skin inflammation. Blood 102, 3295–3301.
11. Dupont, L., Boizet-Bonhoure, B., Coddeville, M., Auvray, F. and Ritzenthaler, P. (1995) Characterisation of genetic elements required for site-specific integration of Lactobacillus delbrueckii subsp. bulgaricus bacteriophage mv4 and construction of an integration proficient vector for Lactobacillus plantarum. J Bacteriol 177, 586–595.
12. Dziarski, R. (1991) Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J Biol Chem 266, 4713–4718.
13. Ernst, P.B., Scicchitano, R., Underdown, B.J. and Bienenstock, J. (1988) Oral immunization and tolerance. In Immunology of the gastrointestinal tract and liver eds. Heyworth, M.F. and Jones, A.L., pp 125–144. New York, N.Y: Raven.
14. Fairweather, N.F., Lyness, V.A. and Maskell, D.J. (1987) Immunisation of mice against tetanus toxin with fragments of tetanus toxin synthesised in Escherichia coli. Infect Immun 55, 2541–2545.
15. Falcone, V., Mihm, D., Neumann-Haefelin, D., Costa, C., Nguyen, T., Pozzi, G. and Ricci, S. (2006) Systemic and mucosal immunity to respiratory sincitial virus induced by recombinant Streptococcus gordonii surface displaying a domain of viral glycoprotein G. FEMS Immunol Med Microbiol 48, 116–122.
16. Fernandes, C.F. and Shahani, K.M. (1990) Anticarcinogenic and immunological properties of dietary lactobacilli. J Food Prot 53, 704–710.
17. Fiat, A.M., Migliore-Samour, D., Jollès, P., Drouet, L., Sollier, C.B. and Caen, J. (1993) Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J Dairy Sci 76, 301–310.
18. Fuller, R. (1997) An introduction. In Probiotics 2: Applications and Practical Aspects ed. Fuller, R., pp 1–9. London, England: Chapman & Hall.
19. Galdeano, C.M., de Moreno de LeBlanc, A., Dogi, C. and Perdigon, G. (2010) Lactic acid bacteria as immunomodulators of the gut - associated immune system. In Biotechnology of lactic acid bacteria: novel applications eds. Mozzi, F, Raya, R. R. and Vignolo, G.M. pp. 124–140. Ames: Wiley-Blackwell.
20. Geoffroy, M.C., Guyard, C., Quatannens, B., Pavan, S., Lange, M. and Mercenier, A. (2000) Use of GreenFluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors. Appl Environ Microbiol 66, 383–391.
21. Gibson, G.R. and Wang, X. (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77, 412–420.
22. Gonzaga, V.E., Lescano, A.G., Huaman, A.A., Salmon-Mulanovich, G. and Blazes, D.I. (2009) Histamine levels in fish from markets in Lima, Peru. J Food Protect 72, 1112–1115.
23. Hanniffy, S.B., Carter, A.T., Hitchin, E. and Wells, J.M. (2007) Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195, 185–193.
24. Havenaar, R., Brink, B.T. and Huis in't Veld, J.H.J. (1992) Selection of strains for probiotic use. In Probiotics, the Scientific Basis ed. Fuller, R. pp. 209–224. London: Chapman and Hall.
25. Havenith, C.E.G., Seegers, J.F.M.L. and Pouwels, P.H. (2002) Gut-associated lactobacilli for oral immunisation. Food Res Int 35, 151–163.
26. He, S., Gong, F., Guo, Y. and Zhang, D. (2012) Food-grade selection markers in lactic acid bacteria. TAF Prev Med Bull 11(4), 499–510.
27. Herias, M.V., Hessle, C., Telemo, E., Midtvedt, T., Hanson, L.A. and Wold, A.E. (1999) Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats. Clin Exp Immunol 116, 283–290.
28. Hershberg, R.M. and Mayer, L.F. (2000) Antigen processing and presentation by intestinal epithelial cells – polarity and complexity. Immunol Today 21, 123–128.
29. Heumann, K.G., Rottman, L. and Vogl, J. (1994) Elemental speciation with liquid chromatography-inductively coupled plasma isotope dilution mass spectrometry. J Anal At Spectrom 9, 1351–1355.
30. Holzapfel, W.H., Haberer, P., Snel, J., Schillinger, U. and Huis in't Veld, J.H.J. (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41, 85–101.
31. Jain, N.K. and Roy, I. (2009) Effect of trehalose on protein structure. Protein Sci 18, 24–36.
32. Jarocki, P., Podleśny, M., Glibowski, P. and Targoński, Z.A. (2014) New insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium. PLoS ONE 9(12), e114379.
33. Kasarello, K., Kwiatkowska-Patzer, B., Lipkowski, A.W., Bardowski, J.K. and Szczepankowska, A.K. (2015) Oral administration of Lactococcus lactis expressing synthetic genes of myelin antigens in decreasing experimental autoimmune encephalomyelitis in rats. Med Sci Monit 21, 1587–1597.
34. Kleerebezem, M., Beerthuyzen, M.M., Vaughan, E.E., de Vos, W.M. and Kuipers, O.P. (1997) Controlled gene expression systems for lactic acid bacteria: transferable nisin-inducible expression cassettes for Lactococcus, Leuconostoc, and Lactobacillus spp. Appl Environ Microbiol 63, 4581–4584.
35. Klijn, N., Weerkamp, A.H. and de Vos, W.M. (1995) Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 61, 2771–2774.
36. Kotloff, K.L., Wasserman, S.S., Jones, K.F., Livio, S., Hruby, D.E., Franke, C.A. and Fischetti, V.A. (2005) Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A Streptococcus vaccine. Infect Immun 3, 2360–2366.
37. Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R. and Flanigan, T.P. (1997) Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65, 1387–1394.
38. Lee, J.S., Poo, H., Han, D.P., Hong, S.P., Kim, K., Cho, M.W., Kim, E., Sung, M.H. et al. (2006) Mucosal immunization with surface-display severe acute respiratory syndrome Coronavirus spike protein on Lactobaclillus casei induces neutralizing antibodies in mice. J Virol 80, 4079–4087.
39. Lee, H.A., Kim, H., Lee, K.W. and Park, K.Y. (2016) Dead Lactobacillus plantarum stimulates and skews immune responses toward T helper 1 and 17 polarizations in RAW 264.7 cells and mouse splenocytes. J Microbiol Biotechnol 26, 469–476.
40. Lidbeck, A. and Nord, C.E. (1993) Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis 16, S181–S187.
41. Martin, R.M. and Lew, A.M. (1998) Is IgG2a a good Th1 marker in mice. Immunol Today 19, 49.
42. Medaglini, D., Pozzi, G., King, T.P. and Fischetti, V.A. (1995) Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonisation. Proc Natl Acad Sci USA 92, 6868–6872.
43. Medaglini, D., Ricci, S., Maggi, T., Rush, C.M., Manganelli, R., Oggioni, M.R. and Pozzi, G. (1997) Recombinant gram-positive bacteria as vehicles of vaccine antigens. Biotechnol Ann Rev 3, 297–312.
44. Mercenier, A., Dutot, P., Kleinpeter, P., Aguirre, M., Paris, P., Reymund, J. and Slos, P. (1996) Development of lactic acid bacteria as live vectors for oral or local vaccines. Adv Food Sci 18, 73–77.
45. Mercenier, A., Müller-Alouf, H. and Grangette, C. (2000) Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2, 17–25.
46. Mestecky, J. (1987) The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7, 265.
47. Meyrand, M., Guillot, A., Goin, M., Furlan, S., Armalyte, J., Kulakauskas, S., Cortes-Perez, N.G., Thomas, G. et al. (2013) Surface proteome analysis of a natural isolate of Lactococcus lctis reveals the presence of pili able to bind human intestinal epithelial cells. Mol Cell Proteomics 12, 3935–3947.
48. Michon, C., Langella, P., Eijsink, V.G.H., Mathiesen, G. and Chatel, J.M. (2016) Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications. Microb Cell Fact 15, 70.
49. Miettinen, M., Vuopio-Varkila, J. and Varkila, K. (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64, 5403–5405.
50. Moineau, S. and Goulet, J. (1991) Effect of feeding fermented milks on the pulmonary macrophage activity in mice. Milchwissenschaft 46, 551–554.
51. Mowat, A.M. and Weiner, H.L. (1999) Oral tolerance: physiological basis and clinical applications. In Mucosal Immunology ed. Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J. and McGhee, J.R., 2nd edn. pp. 587–618. New York, NY: Academic Press.
52. Murray, H.W. (1988) Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med 108, 595–608.
53. Nader de Macías, M.E., Apella, M.C., Romero, N.C., González, S.N. and Oliver, G. (1992) Inhibition of Shigella sonnei by Lactobacillus casei and Lactobacillus acidophilus. J Appl Bacteriol 73, 407–411.
54. Ogra, P.L., Faden, H. and Welliver, R.C. (2001) Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14, 430–445.
55. Oliveira, M.L., Areas, A.P., Campos, I.B., Monedero, V., Perez-Martinez, G., Miyaji, E.N., Leite, L.C., Aire, K.S. et al. (2006) Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8, 1016–1024.
56. Ozawa, K., Fujiwara, R., Watanbe, K. and Sonoyama, K. (2012) Persistence of orally administered Lactobacillus strains in the gut of infant mice. Biosci Microbiota Food Health 31, 85–91.
57. Paubert-Braquet, M., Gan, X.H., Gaudichon, C., Hedef, N., Serikoff, A., Bouley, C., Bonavida, B. and Braquet, P. (1995) Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yoghurt or milks fermented with various Lactobacillus casei strains. Int J Immunother 11, 153–161.
58. Perdigón, G. and Alvarez, S. (1992) Probiotics and the immune state. In Probiotics, the Scientific Basis ed. Fuller, R., pp. 145–180. London: Chapman and Hall.
59. Perdigón, G., Vintiñi, E., Alvarez, S., Medina, M. and Medici, M. (1999) Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 82, 1108–1114.
60. Perdigón, G., Maldonado Galdeano, C., Valdez, J.C. and Medici, M. (2002) Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56(Suppl. 4), S21–S26.
61. Peterbauer, C., Meichsberger, T. and Haltrich, D. (2011) Food-grade gene expression in lactic acid bacteria. Biotechnol J 6, 1147–1161.
62. de Petrino, S.F., de Jorrrat, M.E.B.B., Meson, O. and Perdigón, G. (1995) Protective ability of certain lactic acid bacteria against an infection with Candida albicans in a mouse immunosuppression model by corticoid. Food Agric Immunol 7, 365–373.
63. Plant, K.P. and Lapatra, S.E. (2011) Advances in fish vaccine delivery. Dev Comp Immunol 35, 1256–1262.
64. Pouwels, P.H., Leer, R.J., Shaw, M., Heijne den Bak-Glashouwer, M.J., Tielen, F.D., Smit, E., Martinez, B., Jore, J. et al. (1998) Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 41, 155–167.
65. Radziwill-Bienkowska, J.M., Zochowska, D., Bardowski, J.K., Mercier-Bonin, M. and Kowalczyk, M. (2014) Lactococcus lactis IBB477 presenting adhesive and muco-adhesive properties as a candidate carrier strain for oral vaccination against influenza virus. Acta Biochim Pol 61, 603–607.
66. Radziwill-Bienkowska, J.M., Le, D.T.L., Szczesny, P., Duviau, M.P., Aleksandrzak-Piekarczyk, T., Loubière, P., Mercier-Bonin, M., Bardowski, J.K. et al. (2016) Adhesion of the genome-sequenced Lactococcus lactis subsp. cremoris IBB477 strain is mediated by specific molecular determinants. Appl Microbiol Biotechnol 100, 9605–9617.
67. Ricci, S., Medalgini, D., Rush, C.M., Marcello, A., Peppeloni, S., Manganelli, R., Palu, G. and Pozzi, G. (2000) Immunogenicity of the B Monomer of Escherichia coli HeatLabile toxin expressed on the surface of Streptococcus gordonii. Infect Immun 68, 760–766.
68. Rigaux, P., Daniel, C., Hisbergues, M., Muraille, E., Hols, P., Pot, B., Pestel, J. and Jacquet, A. (2009) Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 64, 406–414.
69. Robinson, K., Chamberlain, L.M., Schofield, K.M., Wells, J.M. and Le Page, R.W.F. (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nature Biotechnol 15, 653–657.
70. Rush, C.M., Mercenier, A. and Pozzi, G. (1997) Expression of vaccine antigens in Lactobacillus. In Gram-Positive Bacteria. Vaccine Vehicles for Mucosal Immunisation. ed. Pozzi, G. and Wells, J.M. pp. 107–144. Landes, Austin, TX: Biotechnology Intelligence Unit.
71. Salminen, S., Isolauri, E. and Salminen, E. (1996) Clinical uses of probiotics for stabilising the gut mucosal barrier: successful strains and future challenges. Anton van Leeuwen 70, 347–358.
72. Sanders, M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J., Hormanseprger, G., Huys, G., Levy, D.D. et al. (2010) Safety assessment of probiotics for human use. Gut Microbes 1, 164–185.
73. Saroja, C.H., Lakshmi, P.K. and Bhaskaran, S. (2011) Recent trends in vaccine delivery systems: a review. Int J Pharm Investig 1, 64–74.
74. Sharma, A., Honma, K., Evans, R.T., Hruby, D.E. and Genco, R.J. (2001) Oral Immunization with Recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains. Infect Immun 69, 2928–2934.
75. Steidler, L. (2003) Gene exchange of ThyA for interleukin-10 eecures live GMO bacterial therapeutics. Discov Med 3, 49–51.
76. Steidler, L., Wells, J.M., Raeymaekers, J., Vandekerckhove, J., Fiers, W. and Remaut, E. (1995) Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microbiol 61, 1627–1629.
77. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W. and Remaut, E. (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352–1355.
78. Szatraj, K., Szczepankowska, A.K., Sączyńska, V., Florys, K., Gromadzka, B., Łepek, K., Płucienniczak, G., Szewczyk, B. et al. (2014) Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis. Acta Biochim Pol 61, 609–614.
79. Tizard, I.R. (2000) An introduction. In: Veterinary immunology ed. Tizard, I.R. 6th edn. pp. 210–221. Philadelphia, PA: Saunders W.B. Company.
80. Toomey, N., Bolton, D. and Fanning, S. (2010) Characterisation and transferability of antibiotic resistance genes from lactic acid bacteria isolated from Irish pork and beef abattoirs. Res Microbiol 161, 127–135.
81. Tortuero, F. and Fernandez, E. (1995) Effect of inclusion of microbial culture in barley-based diets fed to laying hens. Anim Feed Sci Tec 53, 255–265.
82. Tynkkynen, S., Singh, K.V. and Varmanen, P. (1998) Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 41, 195–204.
83. Vidhyalakshmi, R., Parantham, R. and Indhumathi, J. (2009) Amylase production on submerged fermentationby Bacillus spp. World J Chem 4, 89–91.
84. Walker, R.I. (1994) New strategies for using mucosal vaccination to achieve more effective immunisation. Vaccine 12, 387–400.
85. Wang, L., Liu, W., Yang, M., Peng, D. and Chen, L. (2013) Development of a Streptococcus gordonii vaccine strain expressing Schisostoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice. Parasitol Res 112, 1701–1708.
86. Wells, J.M., Norton, P.M. and le Page, R.W.F. (1995) Progress in the development of mucosal vaccines based on Lactococcus lactis. Int Dairy J 5, 1071–1079.
87. Wells, J.M., Robinson, K., Chamberlain, L.M., Schofield, K.M. and Le Page, R.W.F. (1996) Lactic acid bacteria as vaccine delivery vehicles. Anton van Leeuwen 70, 317–330.
88. World Health Organization. Global Vaccine Action Plan: 2011–2020. Geneva, Switzerland: WHO Press; 2013. http://www.who.int/ immunization/global_vaccine_action_plan/en/
89. You, J., Dong, H., Mann, E.R., Knight, S.C. and Yaqoob, P. (2014) Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology 219, 138–148.
90. Yum, J.S., Ahn, B.C., Jin Jo, H.J., Kim, D.Y., Kim, K.H., Kim, H.S., Chul Sung, Y.C., Yoon, J. et al. (2012) Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection. Clin Vaccine Immunol 19, 120–127.
91. Zhou, Z., Gong, S., Li, X.M., Yangm, Y., Guan, R., Zhou, S., Yao, S., Xie, Y. et al. (2015) Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. J Med Microbiol 64, 104–110.